Cargando…
Treatment with Rituximab in the Acute Phase of Relapsing Remitting Multiple Sclerosis
There have been a few reports on the administration of rituximab for relapsing-remitting multiple sclerosis (RRMS) in the acute phase. We report the case of a 62-year-old woman with an acute lesion of RRMS. Although corticosteroid therapy and plasmapheresis were not effective, the lesion improved wi...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Japanese Society of Internal Medicine
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995712/ https://www.ncbi.nlm.nih.gov/pubmed/31462595 http://dx.doi.org/10.2169/internalmedicine.3408-19 |